Literature DB >> 33874

Effect of glucagon and pentagastrin on gastric mucosal potential difference in man.

A Tarnawski, K J Ivey, J E McGuigan, J England.   

Abstract

Glucagon given as an intravenous injection of 2 mg (0.57 mmol) or as constant intravenous infusion of 1.64 microgram/kg/h (0.47 nmol/kg/h) significantly increased gastric mucosal potential difference (PD) in man. Pentagastrin infusion of 2 microgram/kg/h (2.8 nmol/kg/h) dramatically reduced gastric PD in man. The effect of each of these hormones on PD was reversed by the administration of the other. Changes in PD induced by one hormone were not associated with reductions in blood levels of the other. There was an approximate correlation between changes in PD and pH of gastric aspirates, however, the patterns of PD and pH changes were at times dissimilar. This study indicates that administration of gastrointestinal hormones significantly alters gastric mucosal PD in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 33874      PMCID: PMC1412328          DOI: 10.1136/gut.19.12.1116

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Intravenous pentagastrin as a partial agonist of gastric secretion in man: evidence in favor of the existence of hormonal inhibitory sites.

Authors:  M F Prugh; B A Schorr; Z R Vlahcevic; G M Makhlouf
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

2.  Effect of cimetidine on ion fluxes and potential difference across the human stomach.

Authors:  K J Ivey; P A Mackercher
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

3.  Increased gastric mucosal permeability during active secretion in humans.

Authors:  M M Cohen
Journal:  Surg Forum       Date:  1974

4.  The effect of glucagon on pentagastrin-induced gastric acid secretion and serum calcium concentration in man.

Authors:  J Christiansen; L Hendel
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

5.  Determination of pH by the glass electrode: pH meter calibration for gastric analysis.

Authors:  E W Moore
Journal:  Gastroenterology       Date:  1968-04       Impact factor: 22.682

6.  Studies with antibodies to gastrin. Radioimmunoassay in human serum and physiological studies.

Authors:  J E McGuigan; W L Trudeau
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

7.  Effects of histalog and secretin on gastroduodenal profile of pH, potential difference, and pressure in man.

Authors:  S Andersson; M I Grossman
Journal:  Gastroenterology       Date:  1966-07       Impact factor: 22.682

8.  Transmural potential and stimulated acid in innervated rat stomach perfused at pH 3.0.

Authors:  B E Vaughan; H A Ridley; J T Cummins
Journal:  Am J Physiol       Date:  1967-09

9.  Inhibition of gastric acid secretion in man by exogenous and endogenous pancreatic glucagon.

Authors:  J Christiansen; J J Holst; E Kalaja
Journal:  Gastroenterology       Date:  1976-05       Impact factor: 22.682

10.  Effect of cimetidine on gastric potential difference in man.

Authors:  K J Ivey; W Baskin; G Jeffrey
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

View more
  4 in total

1.  Effect of low dose of cimetidine on gastric potentials difference and acetylsalicylic acid-induced change.

Authors:  S Massarrat; V Herbert; R Veith
Journal:  Klin Wochenschr       Date:  1981-08-17

2.  The action of porcine glucagon on the motility of the canine duodenum and jejunum.

Authors:  D F Evans; G E Foster; J D Hardcastle; F Jonhson; J W Wright
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

3.  Effect of human gastrin infusion on gastric potential difference in man.

Authors:  A Tarnawski; J E McGuigan; K J Ivey
Journal:  Dig Dis Sci       Date:  1980-11       Impact factor: 3.199

4.  Effect of pentagastrin on parietal cell ultrastructure in glucagon-pretreated subjects.

Authors:  K J Ivey; A Tarnawski; W J Krause; J Stachura; D Sherman; M Burks
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.